Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Partnership Formed to Support New Drug Discovery Technology

By Biotechdaily staff writers
Posted on 23 Jul 2008
Artel (Westbrook, ME, USA) and IonGate Biosciences announced a strategic partnership to support the growing application of IonGate's (Frankfurt, Germany) drug discovery technology. More...
The German biotechnology company will leverage Artel's local infrastructure, customer relationships, and market knowledge to increase the exposure and use of its discovery systems and assay development services in North America.

The partnership will focus on IonGate's SURFE2R technology, which enables more effective research involving drug targets such as membrane transporters and ligand-gated ion channels.

Membrane transport proteins play an important role in numerous biologic functions, and they have been linked to cardiac, neurologic, and metabolic disorders; however, these proteins represent a relatively unexplored segment of the drug discovery market. The previous lack of technology for efficient transporter screening has led pharmaceutical companies to focus the majority of their research initiatives on other targets. Ligand-gated ion channel proteins, while more frequently targeted, typically are also subject to less-than-optimal screening methods. IonGate's SURFE2R (SURFace Electrogenic Event Reader) technology represents a significant advance toward more efficient screening of transporters as well as ligand-gated ion channels.

"Transporter-focused drug discovery initiatives are poised for rapid growth worldwide, and the U.S. demand for our SURFE2R technology is rising,” said Dr. Thiemo Gropp Ph.D., Managing Director, IonGate Biosciences, GmbH. "With Artek's support and market expertise, we will be able to deliver the same personalized support to our customers in North America as we deliver to our customers in Europe.”

"We chose Artel because of the company's strong relationships with biopharmaceutical companies, highly skilled staff, and deep understanding of our customers' needs,” said Wolfgang Lerch, president, IonGate Biosciences, Inc. "Our companies' synergistic cultures and strong customer-focused orientations will allow us to bring an unparalleled combination of excellent service and technology to the drug discovery industry.”

IonGate's systems are powerful tools for researchers in large pharmaceutical companies as well as academic environments. The systems are valuable for core essential testing, early-stage screening, ADME (absorption, distribution, metabolism, and excretion) studies, and are able to meet the required throughput. A "label-free therefore of higher value, for a growing array of protein targets. The core of this technology is an electrode biochip that measures the electrical activity of membrane-bound proteins. This activity is observed through measurement of the capacitive charging of the sensor chip by ionic species as they are actively transported across the membrane by the protein targets of interest.

IonGate Biosciences develops, produces, and markets innovative screening technologies to investigate transporters and is the worldwide leader in this new area.

Transporters are essential for the metabolic functions of the cell, data processing in the entire organism, and play a fundamental role in the health of humans. Due to their difficult experimental accessibility, transporters are underrepresented in current drug screening processes. Now, IonGate's original product, SURFE2R One, is joined by the SURFE2R Workstation 500 to provide highly precise functional screening of transporters in the higher-throughput pharmaceutical discovery and development environments. IonGate provides total system solutions, encompassing disposables and reagents, consulting services that include the design of assays and customized applications, and contract laboratory services.

Artel's technology, measurement systems, and value-added services are utilized by life-science laboratories to maximize productivity and ensure quality. The Artel MVS and PCS are very accurate, precise, and easy-to-use systems for achieving data integrity in any process requiring liquid handling and volume measurement. Artel services include liquid handling, quality assurance support and consultation, pipetting technique training and certification for pipette users and laboratory managers, and liquid handler performance verification services for automated laboratories.


Related Links:
Artel
IonGate

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Capillary Blood Collection Tube
IMPROMINI M3
Automated MALDI-TOF MS System
EXS 3000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.